Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
35 /100
MEDIUM RISK
Score updated Aug 14, 2026

ABCL — AbCellera Biologics Inc. Dilution Risk Tracker

Track ABCL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ABCL — Get alerts when the score changes →

As of August 14, 2026, AbCellera Biologics Inc. (ABCL) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. AbCellera Biologics Inc. has 306.61M shares outstanding, 140 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
65
📊 Float Risk
12
⚠️ Warrant Exposure
15
🔄Convertible Debt

Dilution Forecast

☀️
Clear
No significant dilution signals
7%
💰 Capital Raise 15%
• Under 12 months cash (11mo)
🔔 Track ABCL — Get forecast alerts →

Market Data

Market CapN/A
Shares Outstanding306.61M
Float206.94M
Cash$120.06M
Debt$190.0K
Short InterestN/A

Institutional Holdings

QoQ: ↑ 31.4% shares (2026Q1 vs prior)
140 institutional holders · 142.73M shares
#1 BAKER BROS. ADVISORS LP 30.28M shares
#2 Capital World Investors 13.36M shares
#3 TWO SIGMA INVESTMENTS, LP 10.56M shares
+ 17 more holders Sign up free to view →

Short Interest

Short Interest48.32M
Days to Cover9.7
% of Float23.4%
FINRA data as of Jul 31, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news
Track ABCL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ABCL — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ABCL
ABCL FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.